Regulation and role of cyclin-dependent kinase activity in neuronal survival and death

Journal of Neurochemistry

Volumn 115, Issue 6, 2010, Pages 1309-1321

  Hisanaga, Shin Ichi ^a   Endo, Ryo ^a  

^a TOKYO METROPOLITAN UNIVERSITY   (Japan)

Author keywords

cyclin dependent kinase 5; death; neurodegenerative diseases; phosphorylation; survival

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CYCLIN B; CYCLIN DEPENDENT KINASE 1; CYCLIN DEPENDENT KINASE 5; CYTOCHROME C; MITOGEN ACTIVATED PROTEIN KINASE 10; NEU DIFFERENTIATION FACTOR; PROTEIN P39;

APOPTOSIS; BINDING AFFINITY; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CELL CYCLE REGULATION; CELL INTERACTION; CELL PROLIFERATION; CELL SURVIVAL; DNA REPLICATION; DOWN REGULATION; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME REGULATION; GENE CLUSTER; GENE FUNCTION; GENETIC ASSOCIATION; HUMAN; MITOSIS; MYRISTYLATION; NERVE CELL NECROSIS; NONHUMAN; OXYGENATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DEPHOSPHORYLATION; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; REVIEW; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION; UBIQUITINATION; UPREGULATION;

ANIMALS; CELL DEATH; CELL SURVIVAL; CYCLIN-DEPENDENT KINASE 5; CYCLIN-DEPENDENT KINASES; ENZYME ACTIVATION; HUMANS; NEURONS;

EID: 78650004185     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2010.07050.x     Document Type: Review

References (142)

1. Amin N. D., Albers W., and, Pant H. C., (2002) Cyclin-dependent kinase 5 (cdk5) activation requires interaction with three domains of p35. J. Neurosci. Res. 67, 354-362.
2. Asada A., Yamamoto N., Gohda M., Saito T., Hayashi N., and, Hisanaga S., (2008) Myristoylation of p39 and p35 is a determinant of cytoplasmic or nuclear localization of active cycline-dependent kinase 5 (Cdk5) complexes. J. Neurochem. 106, 1325-1336.
3. Ballif B. A., Villén J., Beausoleil S. A., Schwartz D., and, Gygi S. P., (2004) Phosphoproteomic analysis of the developing mouse brain. Mol. Cell Proteomics 3, 1093-1101.
4. Benavides D. R., and, Bibb J. A., (2004) Role of Cdk5 in drug abuse and plasticity. Ann. N Y Acad. Sci. 1025, 335-344.
5. Bogush A., Pedrini S., Pelta-Heller J., Chan T., Yang Q., Mao Z., Sluzas E., Gieringer T., and, Ehrlich M. E., (2007) AKT and CDK5/p35 mediate brain-derived neurotrophic factor induction of DARPP-32 in medium size spiny neurons in vitro. J. Biol. Chem. 282, 7352-7359.
6. Brinkkoetter P. T., Olivier P., Wu J. S., Henderson S., Krofft R. D., Pippin J. W., Hockenbery D., Roberts J. M., and, Shankland S. J., (2009) Cyclin I activates Cdk5 and regulates expression of Bcl-2 and Bcl-XL in postmitotic mouse cells. J. Clin. Invest. pii, 37978; doi: 10.1172/JCI37978.
7. Brinkkoetter P. T., Pippin J. W., and, Shankland S. J., (2010) Cyclin I-Cdk5 governs survival in post-mitotic cells. Cell Cycle 9, 1729-1971.
8. Bu B., Li J., Davies P., and, Vincent I., (2002) Deregulation of cdk5, hyperphosphorylation, and cytoskeletal pathology in the Niemann-Pick type C murine model. J. Neurosci. 22, 6515-6525.
9. Cancino G. I., De Arce K. P., Castro P. U., Toledo E. M., Von Bernhardi R., and, Alvarez A. R., (2009) c-Abl tyrosine kinase modulates tau pathology and Cdk5 phosphorylation in AD transgenic mice. Neurobiol. Aging (in press).
10. Chae T, Kwon Y. T., Bronson R., Dikkes P., Li E., and, Tsai L. H., (1997) Mice lacking p35, a neuronal specific activator of Cdk5, display cortical lamination defects, seizures, and adult lethality. Neuron 18, 29-42.
11. Chang Y., Ostling P., Akerfelt M., et al. (2006) Role of heat-shock factor 2 in cerebral cortex formation and as a regulator of p35 expression. Genes Dev. 20, 836-847.
12. Chang K. H., De Pablo Y., Lee H. P., Lee H. G., Smith M. A., and, Shah K., (2010) Cdk5 is a major regulator of p38 cascade: relevance to neurotoxicity in Alzheimer's disease. J. Neurochem. 113, 1221-1229.
13. Cheng Q., Sasaki Y., Shoji M., Sugiyama Y., Tanaka H., Nakayama T., Mizuki N., Nakamura F., Takei K., and, Goshima Y., (2003) Cdk5/p35 and Rho-kinase mediate ephrin-A5-induced signaling in retinal ganglion cells. Mol. Cell. Neurosci. 24, 632-645.
14. Cheung Z. H., and, Ip N. Y., (2004) Cdk5: mediator of neuronal death and survival. Neurosci. Lett. 361, 47-51.
15. Cheung Z. H., and, Ip NY., (2007) The roles of cyclin-dependent kinase 5 in dendrite and synapse development. Biotechnol. J. 2, 949-957.
16. Cheung Z. H., Chin W. H., Chen Y., Ng Y. P., and, Ip N. Y., (2007) Cdk5 is involved in BDNF-stimulated dendritic growth in hippocampal neurons. PLoS Biol. 5, 865-877.
17. Cheung Z. H., Gong K., and, Ip N. Y., (2008) Cyclin-dependent kinase 5 supports neuronal survival through phosphorylation of Bcl-2. J. Neurosci. 28, 4872-4877.
18. Clayton E. L., Evancs G. J. O., and, Cousin M. A., (2007) Activity-dependent control of bulk endocytosis by protein dephosphorylation in central nerve terminals. J. Physiol. 585, 687-691.
19. Cole A. R., Noble W., Van Aalten L., et al. (2007) Collapsin response mediator protein-2 hyperphosphorylation is an early event in Alzheimer's disease progression. J. Neurochem. 103, 1132-1144.
20. Cruz J. C., and, Tsai L. H., (2004) Cdk5 deregulation in the pathogenesis of Alzheimer's disease. Trends Mol. Med. 10, 452-458.
21. Cruz J. C., Tseng H. C., Goldman J. A., Shih H., and, Tsai L. H., (2003) Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles. Neuron 40, 471-483.
22. Cruz J. C., Kim D., Moy L. Y., Dobbin M. M., Sun X., Bronson R. T., and, Tsai L-H., (2006) p25/cyclin-dependent kinase 5 induces production and intraneuronal accumulation of amyloid β in vivo. J. Neurosci. 26, 10536-10541.
23. Desbarats J., Birge R. B., Mimouni-Rongy M., Weinstein D. E., Palerme J. S., and, Newell M. K., (2003) Fas engagement induces neurite growth through ERK activation and p35 upregulation. Nat. Cell Biol. 5, 118-125.
24. Dhavan R., and, Tsai L. H., (2001) A decade of CDK5. Nat. Rev. Mol. Cell Biol. 2, 749-759.
25. Endo R., Saito T., Asada A., Kawahara H., Ohshima T., and, Hisanaga S., (2009) Commitment of MPP+-induced neuronal cell death by proteasome-mediated degradation of p35 Cdk5 activator. J. Biol. Chem. 284, 26029-26039.
26. Fattaey A., and, Booher R. N., (1997) Myt1: a Wee1-type kinase that phosphorylates Cdc2 on residue Thr14. Prog. Cell Cycle Res. 3, 233-240.
27. Fu A. K., Fu W. Y., Ng A. K., Chien W. W., Ng Y. P., Wang J. H., and, Ip N. Y., (2004) Cyclin-dependent kinase 5 phosphorylates signal transducer and activator of transcription 3 and regulates its transcriptional activity. Proc. Natl Acad. Sci. USA 101, 6728-6233.
28. Fu W. Y., Chen Y., Sahin M., et al. (2007) Cdk5 regulates EphA4-mediated dendritic spine retraction through an ephexin1-dependent mechanism. Nat. Neurosci. 10, 67-76.
29. Gong X., Tang X., Wiedmann M., Wang X., Peng J., Zheng D., Blair L. A. C., Marshall J., and, Mao Z., (2003) Cdk5-mediated inhibition of the protective effects of transcription factor MEF2 in neurotoxicity-induced apoptosis. Neuron 38, 33-46.
30. Gu Y., Hamajima N., and, Ihara Y., (2000) Neurofibrillary tangle-associated collapsin response mediator protein-2 (CRMP-2) is highly phosphorylated on Thr-509, Ser-518, and Ser-522. Biochemistry 39, 4267-4275.
31. Hamdane M., Bretteville A., Samob A-V., Schindowski K., Begard S., Delacourte A., Bertrand P., and, Buee L., (2005) p25/Cdk5-mediated retinoblastoma phosphorylation is an early event in neuronal cell death. J. Cell Sci. 118, 1291-1298.
32. Harada T., Morooka T., Ogawa S., and, Nishida E., (2001) ERK induces p35, a neuron-specific activator of Cdk5, through induction of Egr1. Nat. Cell Biol. 3, 453-459.
33. Hashiguchi M., Saito T., Hisanaga S., and, Hashiguchi T., (2002) Truncation of CDK5 activator p35 induces intensive phosphorylation of Ser202/Thr205 of human tau. J. Biol. Chem. 277, 44525-44530.
34. Hawasli A. H., and, Bibb J. A., (2007) Alternative roles for Cdk5 in learning and synaptic plasticity. Biotechnol. J. 2, 941-948.
35. Hawasli A. M., Benavides D. R., Nguyen C., Kansy J. W., Hayashi K., Chambon P., Greengard P., Powell C. M., Cooper D. C., and, Bibb J. A., (2007) Cyclin-dependent kinase 5 governs learning and synaptic plasticity via control of NMDAR degradation. Nat. Neuroosci. 10, 880-886.
36. Hisanaga S., and, Saito T., (2003) The regulation of cyclin-dependent kinase 5 activity through the metabolism of p35 or p39 Cdk5 activator. Neurosignals 12, 221-229.
37. Hisanaga S., Uchiyama M., Hosoi T., Yamada K., Honma N., Ishiguro K., Uchida T., Dahl D., Ohsumi K., and, Kishimoto T., (1995) Porcine brain neurofilament-H tail domain kinase: Its identification as cdk5/p26 complex and comparison with cdc2/cyclin B kinase. Cell Motil. Cytoskel. 31, 283-297.
38. 2+/calmodulin-dependent protein kinase II upon downregulation of Cyclin-dependent kinase 5-p35. J. Neurosci. Res. 84, 747-754.
39. Huang E., Qu D., Zhang Y., Vendorova K., Haque M. E., Rousseaux M. W. C., Slack R. S., Woulfe J. M., and, Park D. S., (2010) The role of Cdk5-mediataed apurinic/apyrimidinic endonuclease 1 phosphorylaiton in neuronal death. Nat. Cell Biol. 12, 563-571.
40. Humbert S., Dhavan R., and, Tsai L.-H., (2000) p39 activates cdk5 in neurons, and is associated with the actin cytoskeleton. J. Cell Sci. 113, 975-983.
41. Jeong Y. G., Rosales J. L., Marzban H., Sillitoe R. V., Park D. G., Hawkes R., and, Lee K. Y., (2003) The cyclin-dependent kinase 5 activator, p39, is expressed in stripes in the mouse cerebellum. Neuroscience 118, 323-334.
42. Jorda E. G., Verdaguer E., Canudas A. M., Jimenez A., Garcia De Arriba S., Allgaier C., Pllas M., and, Camins A., (2005) Implication of cyclin-dependnet kinase 5 in the neuroprotective properties of Lithium. Neuroscience 134, 1001-1011.
43. Kamei H., Saito T, Ozawa O., Fujita Y., Asada A., Bibb J. A., Saido T. C., Sorimachi S., and, Hisanaga S., (2007) Supression of calpain-dependent cleavage of the cdk5 activator p35 to p25 by site-specific phosphorylation. J. Biol. Chem. 282, 1687-1694.
44. Kanungo J., Li B-S., Zheng Y., and, Pant H. C., (2006) Cyclin-dependent kinase 5 influences Rohon-Beard neuron survival in zebrafish. J. Neurochem. 99, 251-259.
45. Kawauchi T., and, Hoshino M., (2008) Molecular pathways regulating cytoskeletal organization and morphological changes in migrating neurons. Dev. Neurosci. 30, 36-46.
46. Kerokoski P., Suuronen T., Salminen A., Soininen H., and, Pirttila T., (2002) Influence of phosphorylation of p35, an activator of cyclin-dependent kinase 5 (cdk5), on the proteolysis of p35. Brain Res. Mol. Brain Res. 106, 50-56. (Pubitemid 35223279)
47. Kesavapany S., Li B.-S., Amin N., Zhen Y.-L., Grant P., and, Pant H. C., (2004) Neuronal cyclin-dependent kinase 5: role in nervous system function and its specific inhibition by the Cdk5 inhibitory peptide. Biochim. Biophys. Acta 1697, 143-153.
48. Kikuchi S., Fujimoto K., Kitagawa N., Fuchikawa T., Abe M., Oka K., Takei K., and, Tomita M., (2003) Kinetic simulation of signal transduction system in hippocampal long-term potentiation with dynamic modeling of protein phosphatase 2A. Neural Netw. 16, 1389-1398.
49. Kim D., Frank C. L., Dobbin M. M., et al. (2008) Deregulation of HDAC1 by p25/Cdk5 in neurotoxicity. Neuron 60, 803-817.
50. Ko J., Humbert S., Bronson R. T., Takahashi S., Kulkarni A. B., Li E., and, Tsai L.-H., (2001) p35 and p39 are essential for cyclin-dependent kinase 5 function during neurodevelopment. J. Neurosci. 21, 6758-6871.
51. Kusakawa G., Saito T., Onuki R., Ishiguro K., Kishimoto T., and, Hisanaga S., (2000) Calpain-dependent proteolytic cleavage of the p35 cyclin-dependent kinase 5 activator to p25. J. Biol. Chem. 275, 17166-17172.
52. Lai K. O., and, Ip N. Y., (2009) Recent advances in understanding the roles of Cdk5 in synaptic plasticity. Biochim. Biophys. Acta 1792, 741-745.
53. Ledee D. R., Gao C. Y., Seth R., Fariss R. N., Tripathi B. K., and, Zelenka P. S., (2005) A specific interaction between muskelin and the cyclin-dependent kinase 5 activator p39 promotes peripheral localization of muskelin. J. Biol. Chem. 280, 21376-21383.
54. Lee J.-H., and, Kim K.-T., (2004) Induction of cyclin-dependent kinase 5 and its activator p35 through the extracellular-signal-regulated kinase and protein kinase A pathways during retinoic-acid mediated neuronal differentiation in human neuroblastoma SK-N-BE(2)C cells. J. Neurochem. 91, 634-647.
55. Lee K. Y., Rosales J. L., Tang D., and, Wang J. H., (1996) Interaction of cyclin-dependent kinase 5 (Cdk5) and neuronal Cdk5 activator in bovine brain. J. Biol. Chem. 271, 1538-1543.
56. Lee K. Y., Helbing C. C., Choi K. S, Johnston R. N., and, Wang J. H., (1997a) Neuronal Cdc2-like kinase (Nclk) binds and phosphorylates the retinoblastoma protein. J. Biol. Chem. 272, 5622-5626.
57. Lee K. Y., Qi Z., Yu Y. P., and, Wang J. H., (1997b) Neuronal Cdc2-like kinases: neuron-specific forms of Cdk5. Int. J. Biochem. Cell Biol. 29, 951-958.
58. Lee M. S., Kwon Y. T., Li M., Peng J., Friedlander R. M., and, Tsai L.-H., (2000) Neurotoxicity induces cleavage of p35 to p25 by calpain. Nature 405, 360-364.
59. Lee J.-H., Kim H.-S., Lee S.-H., and, Kim K.-T., (2007) Stabilization and activation of p53 induced by Cdk5 contributes to neuronal cell death. J. Cell Sci. 120, 2259-2271.
60. Lee J.-H., Jeong M.-W., Kim W., Choi Y. H., and, Kim K.-T., (2008) Cooperative roles of c-Able and Cdk5 in regulation of p53 in response to oxidative stress. J. Biol. Chem. 283, 19826-19835.
61. 1-mediated activation of cyclin-dependent kinase 5 activity is involved in neurite outgrowth and human neurofilament protein H Lys-Ser-Pro tail domain phosphorylation. J. Neurosci. 20, 6055-6062.
62. Li B. S., Zhang L., Takahashi S., Ma W., Jaffe H., Kulkarni A. B., and, Pant H. C., (2002) Cyclin-dependent kinase 5 prevents neuronal apoptosis by negative regulation of c-Jun N-terminal kinase 3. EMBO J. 21, 324-333.
63. Li B. S., Ma W., Jaffe H., Zheng Y., Takahashi S., Zhang L., Kulkarni A. B., and, Pant H. C., (2003) Cyclin-dependent kinase-5 is involved in neuregulin-dependent activation of phosphatidylinositol 3-kinase and Akt activity mediating neuronal survival. J. Biol. Chem. 278, 35702-35709.
64. Li T., Chalifour L. E., and, Paudel H. K., (2007) Phosphorylation of protein phosphatase 1 (PP1) by cyclin-dependent protein kinase 5 during nerve growth factor-induced PC12 cell differentiation. J. Biol. Chem. 282, 6619-6628.
65. Lin H., Lin T. Y., and, Juang J. L., (2007) Abl deregulates Cdk5 kinase activity and subcellular localization in Drosophila neurodegeneration. Cell Death Differ. 14, 607-615.
66. Mapelli M., and, Musacchio A., (2003) The structural perspective on CDK5. Neurosignals 12, 164-172.
67. Matsuura I., and, Wang J. H., (1996) Demonstration of cyclin-dependent kinase inhibitory serine/threonine kinase in bovine thymus. J. Biol. Chem. 271, 5443-5450.
68. Meuer K., Suppanz I. E., Lingor P., et al. (2007) Cyclin-dependenti kinase 5 is an upstream regulator of mitochondrial fission during neuronal apoptosis. Cell Death Diff. 14, 651-661.
69. Meyerson M., Enders G. H., Wu C.-L., Su L.-K., Gorka C., Nelson C., Harlow E., and, Tsai L.-H., (1992) A family of human cdc2-related protein kinases. EMBO J. 11, 2909-2917.
70. Minegishi S., Asada A., Miyauchi S., Fuchigami T., Saito T., and, Hisanaga S., (2010) Membrane association facilitates degradation and cleavage of the cyclin-dependent kinase 5 activators p35 and p39. Biochemistry 49, 5482-5493.
71. Miyamoto Y., Yamauchi J., and, Tanoue A., (2008) Cdk5 phosphorylation of WAVE2 regulates oligodendrocyte precursor cell migration through nonreceptor tyrosine kinase Fyn. J. Neurosci. 28, 8326-8337.
72. Morgan D. O., (1997) Cyclin-dependent kinases: engines, clocks, and microprocessors. Annu. Rev. Cell Dev. Biol. 13, 261-291.
73. Nakamura T., Sanokawa R., Sasaki Y. F., Ayusawa D., Oishi M., and, Mori N., (1995) Cyclin I: a new cyclin encoded by a gene isolated from human brain. Exp. Cell Res. 221, 534-542.
74. Nakayama K.-I., and, Nakayama K., (2006) Ubiquitin ligases: cell-cycle control and cancer. Nat. Rev. Cancer 6, 369-381.
75. Nguyen M. D., Larivière R. C., and, Julien J. P., (2001) Deregulation of Cdk5 in a mouse model of ALS: toxicity alleviated by perikaryal neurofilament inclusions. Neuron 30, 135-147.
76. Nguyen K. C., Rosales J. L., Barboza M., and, Lee K. Y., (2002) Controversies over p25 in Alzheimer's disease. J. Alzheimers Dis. 4, 123-126.
77. Noble W., Olm V., Takata K., et al. (2003) Cdk5 is a key factor in tau aggregation and tangle formation in vivo. Neuron 38, 555-565.
78. O'Hare M. J., Kushwaha N., Zhang Y., Aleyasin H., Callaghan S. M., Slack R. S., Albert P. R., Vincent I., and, Park D. S., (2005) Differential roles of nuclear and cytoplasmic cyclin-dependent kinase 5 in apoptotic and excitotoxic neuronal death. J. Neurosci. 25, 8954-8966.
79. Ohshima T., Ward J. M., Huh C. G., Longenecker G., Veeranna, Pant H. C., Brady R. O., Martin L. J., and, Kulkarni A. B., (1996) Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death. Proc. Natl Acad. Sci. USA 93, 11173-11178.
80. Ohshima T., Ogura H., Tomizawa K., et al. (2005) Impairment of hippocampal long-term depression and defective spatial learning and memory in p35 mice. J. Neurochem. 94, 917-925.
81. Paglini G., Pigino G., Kunda P., Morfini G., Maccioni R., Quiroga S., Ferreira A., and, Caceres A., (1998) Evidence for the participation of the neuron-specific CDK5 activator p35 during laminin-enhanced axonal growth. J. Neurosci. 18, 9858-9869.
82. Paoletti P., Vila I., Rifé M., Lizcano J. M., Alberch J., and, Ginés S., (2008) Dopaminergic and glutamatergic signaling crosstalk in Huntington's disease neurodegeneration: the role of p25/cyclin-dependent kinase 5. J. Neurosci. 28, 10090-10101.
83. Pareek T. K., Keller J., Kesavapany S., Pant H. C., Iadarola M. J., Brady R. O., and, Kulkarni A. B., (2006) Cyclin-dependent kinase 5 activity regulates pain signaling. Proc. Natl Acad. Sci. USA 103, 91-96.
84. Patrick G. N., Zhou P., Kwon Y. T., Howley P. M., and, Tsai L.-H., (1998) p35, the neuronal-specific activator of cyclin-dependent kinase 5 (Cdk5) is degraded by the ubiquitin-proteasome pathway. J. Biol. Chem. 273, 24057-24064.
85. Patrick G. N., Zukerberg L., Nikolic M., De La Monte S., Dikkes P., and, Tsai L.-H., (1999) Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature 402, 615-622.
86. Patzke H., and, Tsai L.-H., (2002) Calpain-mediated cleavage of the cyclin-dependent kinase-5 activator p39 to p29. J. Biol. Chem. 277, 8054-8060.
87. Peterson D. W., Ando D. M., Taketa D. A., Zhou H., Dahlquist F. W., and, Lew J., (2010) No difference in kinetics of tau or histone phosphorylation by CDK5/p25 versus CDK5/p35 in vitro. Proc. Natl Acad. Sci. USA 107, 2884-2889.
88. Poon R. Y., Lew J, and, Hunter T., (1997) Identification of functional domains in the neuronal Cdk5 activator protein. J. Biol. Chem. 272, 5703-5708.
89. Qi Z., Huang Q. Q., Lee K. Y., Lew J., and, Wang J. H., (1995) Reconstitution of neuronal Cdc2-like kinase from bacteria-expressed Cdk5 and an active fragment of the brain-specific activator. J. Biol. Chem. 27, 10847-10854.
90. Qu D., Rashidian J., Mount M. P., et al. (2007) Role of Cdk5-meidiated phosphorylation of Prx2 in MPTP toxicity and Parkinson's disease. Neuron 55, 37-52.
91. Rashidian J., Rousseaux M. W., Venderova K., et al. (2009) Essential role of cytoplasmic cdk5 and Prx2 in multiple ischemic injury models, in vivo. J. Neurosci. 29, 12497-12505.
92. Russo A. A., Jeffrey P. D., and, Pavletich N. P., (1996) Structural basis of cyclin-dependent kinase activation by phosphorylation. Nat. Struct. Biol. 3, 696-700.
93. Saito T., Ishiguro K., Onuki R., Nagai Y., Kishimoto T., and, Hisanaga S., (1998) Okadaic acid-stimulated degradation of p35, an activator of CDK5, by proteasome in cultured neurons. Biochem. Biophys. Res. Commun. 252, 775-778.
94. Saito T., Onuki R., Fujita Y., Kusakawa G., Ishiguro K., Bibb J. A., Kishimoto T., and, Hisanaga S., (2003) Developmental regulation of the proteolysis of the p35 cyclin-dependent kinase 5 activator by phosphorylation. J. Neurosci. 23, 1189-1197. (Pubitemid 36258898)
95. Saito T., Konno T., Hosokawa T., Asada A., Ishiguro K., and, Hisanaga S., (2007) p25/Cyclin-dependent kinase 5 promotes the progression of cell death in nucleus of endoplasmic reticulum-stressed neurons. J. Neurochem. 102, 133-140.
96. Sakaue F., Saito T., Sato Y., Asada A., Ishiguro K., Hasegawa M., and, Hisanaga S., (2005) Phosphorylation of FTDP-17 mutant tau by cyclin-dependent kinase 5 complexed with p35, p25, or p39. J. Biol. Chem. 280, 31522-31529.
97. Sananbenesi F., Fischer A., Wang X., Schrick C., Neve R., Radulovic J., and, Tsai L-H., (2007) A hippocampal Cdk5 pathway regulates extinction of contextual fear. Nat. Neurosci. 10, 1012-1019.
98. Sasaki Y., Cheng C., Uchida Y., et al. (2002) Fyn and Cdk5 mediate semaphorin-3A signaling, which is involved in regulation of dendrite orientation in cerebral cortex. Neuron 35, 907-920.
99. Sato Y., Taoka M., Sugiyama N., Kubo K., Fuchigami T., Asada A., Saito T., Nakajima K., Isobe T., and, Hisanaga S., (2007) Regulation of the interaction of disabled-1 with CIN85 by phosphorylation with cyclin-dependent kinase 5. Genes Cells 12, 1315-1327. (Pubitemid 350215136)
100. Sharma P., Veeranna, Sharma M., Amin N. D., Sihag R. K., Grant P., Ahn N., Kulkarni A. B., and, Pant H. C., (2002) Phosphorylation of MEK1 by cdk5/p35 down-regulates the mitogen-activated protein kinase pathway. J. Biol. Chem. 277, 528-534.
101. Smith P. D., Crocker S. J., Jackson-Lewis V., et al. (2003) Cyclin-dependent kinase 5 is a mediator of dopaminergic neuron loss in a mouse model of Parkinson's disease. Proc. Natl Acad. Sci. USA 100, 13650-13655.
102. Smith P. D., Mount M. P., Shree R., Callaghan S., Slack R. S., Anisman H., Vincent I., Wang X., Mao Z., and, Park D. S., (2006) Calpain-regulated p35/cdk5 plays a central role in dopaminergic neuron death through modulation of the transcription factor myocyte enhancer factor 2. J. Neurosci. 26, 440-447.
103. Song J. H., Wang C. X., Song D. K., Wang P., Shuaib A., and, Hao C., (2005) Interferon γ induces neurite outgrowth by up-regulation of p35 neuron-specific cyclin-dependent kinase 5 activator via activation of ERK1/2 pathway. J. Biol. Chem. 280, 12896-128901.
104. Sun K. H., De Pablo Y., Vincent F., and, Shah K., (2008) Deregulated Cdk5 promotes oxidative stress and mitochondrial dysfunction. J. Neurochem. 107, 2652-2678.
105. Sun K-H., Lee H.-G., Smith M. A., and, Shah K., (2009) Direct and indirect roles of cyclin-dependent kinase 5 as an upstream regulator in the c-Jun NH2-terminal kinase cascade: relevance to neurotoxic insults in Alzheimer's disease. Mol. Biol. Cell 20, 4611-4619.
106. Takahashi S., Saito T., Hisanaga S., Pant H. C., and, Kulkarni A. B., (2003) Tau phosphorylation by cyclin-dependent kinase 5/p39 during brain development reduces its affinity for microtubules. J. Biol. Chem. 278, 10506-10515.
107. Takahashi S., Ohshima T., Hirasawa M., Pareek T. K., Bugge T. H., Morozov A., Fujieda K., Brady R. O., and, Kulkarni A. B., (2010) Conditional deletion of neuronal cyclin-dependent kinase 5 in developing fore brain results in microglial activation and neurodegeneration. Am. J. Pathol. 176, 320-329.
108. Tanaka T., Veeranna, Ohshima T., Rajan P., Amin N. D., Cho A., Sreenath T., Pant H. C., Brady R. O., and, Kulkarni A. B., (2001) Neuronal cyclin-dependent kinase 5 activity is critical for survival. J. Neurosci. 21, 550-558.
109. Tandon A., Yu H., Wang L., et al. (2003) Brain levels of CDK5 activator p25 are not increased in Alzheimer's or other neurodegenerative diseases with neurofibrillary tangles. J. Neurochem. 86, 572-581.
110. Tang D., and, Wang J. H., (1996) Cyclin-dependent kinase 5 (Cdk5) and neuron-specific Cdk5 activators. Prog. Cell Cycle Res. 2, 205-216.
111. Tang D., Yeng J., Lee K. Y., Matsushita M., Matsui H., Tomizawa K., Hatase O., and, Wang J. H., (1995) An isoform of the neuronal cyclin-dependent kinase 5 (Cdk5) activator. J. Biol. Chem. 270, 26897-26903.
112. Tang D., Chun A. C., Zhang M., and, Wang J. H., (1997) Cyclin-dependent kinase 5 (Cdk5) activation domain of neuronal Cdk5 activator. J. Biol. Chem. 272, 2318-2327.
113. Tang X., Wang X., Gong X., Tong M., Park D., Xia Z., and, Mao Z., (2005) Cyclin-dependent kinase 5 mediates neurotoxin-induced degradation of the transcription factor myocyte enhancer factor2. J. Neurosci. 25, 4823-4834.
114. Taniguchi S., Fujita Y., Takahashi H., Hayashi S., Kakita A., Murayama S., Saido T., Hisanaga S., Iwatsubo T., and, Hasegawa M., (2001) Calpain-mediated degradation of p35 to p25 in postmortem human and rat brains. FEBS Lett. 489, 46-50.
115. Tarricone C., Dhavan R., Peng J., Areces L. B., Tsai L-H., and, Musacchio A., (2001) Structure and regulation of the CDK5-p25nck5a complex. Mol. Cell 8, 657-669.
116. Tian B., Yang Q., and, Mao Z., (2009) Phosphorylaiton of ATM by Cdk5 mediates DNA damage signaling and regulates neuronal death. Nat. Cell Biol. 11, 211-218.
117. Tokuoka H., Saito T., Yorifuji H., Wei F., Kishimoto T., and, Hisanaga S., (2000) Brain-derived neurotrophic factor-induced phosphorylation of neurofilament-H subunit in primary cultures of embryo rat cortical neurons. J. Cell Sci. 113, 1059-1068.
118. Tsai L.-H., Takahashi T., Caviness V. S., Jr, and, Harlow E., (1993) Activity and expression pattern of cyclin-dependent kinase 5 in the embryonic mouse nervous system. Development 119, 1029-1040.
119. Tsai L.-H., Delalle I., Caviness V. S., Chae T., and, Harlow E., (1994) p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5. Nature 371, 419-423.
120. Tseng H. C., Zhou Y., Shen Y., and, Tsai L.-H., (2002) A survey of Cdk5 activator p35 and p25 levels in Alzheimer's disease brains. FEBS Lett. 523, 58-62.
121. Utreras E., Futatsugi A., Rudrabhatla P., Keller J., Iadarol M. J., Pant H. C., and, Kulkarni A.B., (2009) Tumor necrosis factor-α regulates cyclin-dependent kinase 5 activity during pain signaling through transcriptional activation of p35. J. Biol. Chem. 284, 2275-2284.
122. Vartiainen N., Keksa-Goldsteine V., Goldsteins G., and, Koistinaho J., (2002) Aspirin provides cyclin-dependent kinase 5-dependent protection against subsequent hypoxia/reoxygenation damage in culture. J. Neurochem. 82, 329-335.
123. Varvel N. H., Bhaskar K., Patil A. R., Pimplikar S. W., Herrup K., and, Lamb B. T., (2008) Aβ oligomers induce neuronal cell cycle events in Alzheimer's disease. J. Neurosci. 28, 10786-10793.
124. Vincent I., Jicha G., Rosado M., and, Dickson D. W., (1997) Aberrant expression of mitotic cdc2/cyclin B1 kinase in degenerating neurons of Alzheimer's disease brain. J. Neurosci. 17, 3588-3598.
125. Wang C. X., Song J. H., Song D. K., Yong V. W., Shuaib A., and, Hao C., (2006a) Cyclin-dependent kinase-5 prevents neuronal apoptosis through ERK-mediated upregulation of Bcl-2. Cell Death Differ. 13, 1203-1212.
126. Wang Y., Xie W. Y., He Y., et al. (2006b) Role of CDK5 in neuroprotection from serum deprivation by μ-opioid receptor agonist. Exp. Neurol. 202, 313-323.
127. Wang Y., White M. G., Akay C., et al. (2007) Activation of cyclin-dependent kinase 5 by calpains contributes to human immunodeficiency virus-induced neurotoxicity. J. Neurochem. 103, 439-455.
128. Wei F. Y., Tomizawa K., Ohshima T., et al. (2005) Control of cyclin-dependent kinase 5 (Cdk5) activity by glutamatergic regulation of p35 stability. J. Neurochem. 93, 502-512.
129. Wen Y., Yu W. H., Maloney B., et al. (2008) Transcriptional regulation of b-secretase by p25/Cdk5 leads to enhanced amyloidogenic processing. Neuron 57, 680-690.
130. Wu D. C., Yu Y. P., Lee N. T., Yu A. C., Wang J. H., and, Han Y. F., (2000) The expression of Cdk5, p35, p39, and Cdk5 kinase activity in developing, adult, and aged rat brains. Neurochem. Res. 25, 923-929.
131. Yamada M., Saito T., Sato Y., Kawai Y., Sekigawa A., Hamazumi Y., Asada A., Wada M., Doi H., and, Hisanaga S., (2007) Cdk5-p39 is a labile complex with the similar substrate specificity to Cdk5-p35. J. Neurochem. 102, 1477-1487.
132. Yang Y., and, Herrup K., (2005) Loss of neuronal cell cycle control in ataxia-telangiectasia: a unified disease mechanism. J. Neurosci. 25, 2522-2529.
133. Yang Y., Geldmacher D. S., and, Herrup K., (2001) DNA replication precedes neuronal cell death in Alzheimer's disease. J. Neurosci. 21, 2661-2668.
134. Yang Y. R., He Y., Zhang Y., Li Y., Li Y., Han Y., Zhu H., and, Wang Y., (2007) Activation of cyclin-dependent kinase 5 (Cdk5) in primary sensory and dorsal horn neurons by peripheral inflammation contributes to heat hyperalgesia. Pain 127, 109-120.
135. Yoo B. C., and, Lubec G., (2001) p25 protein in neurodegeneration. Nature 411, 763-764.
136. Zhang J., Krishnamurthy P. K., and, Johnson G. V. W., (2002) Cdk5 phosphorylates p53 and regulates its activity. J. Neurochem. 81, 307-313.
137. Zhang J., Li H., Yabut O., Fitzpatrick H., D'Arcangelo G., and, Herrup K., (2010) Cdk5 suppresses the neuronal cell cycle by disrupting the E2F1-DP1 complex. J. Neurosci. 30, 5219-5228.
138. Zhao C. T., Li K., Li J. T., Zheng W., Liang X. J., Geng A. Q., Li N., and, Yuan X. B., (2009) PKCδ regulates cortical radial migration by stabilizing the Cdk5 activator p35. Proc. Natl Acad. Sci. USA 106, 21353-21358.
139. Zheng M., Leung C. L., and, Liem R. K. H., (1998) Region-specific expression of cyclin-dependent kinase 5 (cdk5) and its activators, p35 and p39, in the developing and adult rat central nervous system. J. Neurobiol. 35, 141-159.
140. Zheng Y. L., Li B. S., Kanungo J., Kesavapany S., Amin N., Grant P., and, Pant H. C., (2007) Cdk5 modulation of mitogen-activated protein kinase signaling regulates neuronal survival. Mol. Biol. Cell 18, 404-413.
141. Zhu Y. S., Saito T., Asada A., Maekawa S., and, Hisanaga S., (2005) Activation of latent cyclin-dependent kinase 5 (Cdk5)-p35 complexes by membrane dissociation. J. Neurochem. 94, 1535-1545.
142. Zukerberg L. R., Patrick G. N., Nikolic M., et al. (2000) Cables links Cdk5 and c-Abl and facilitates Cdk5 tyrosine phosphorylation, kinase upregulation, and neurite outgrowth. Neuron 26, 633-646.